Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Immunopharmacology|December 1, 1994
Toxicity of high doses of polyclonal drug-specific antibody Fab fragmentsD E Keyler, W L Shelver, J Landon, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in ratsD E Keyler, D Shoeman, M G LeSage, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|July 1, 1991
Rapid administration of high-dose human antibody Fab fragments to dogs: pharmacokinetics and toxicityD E Keyler, D M Salerno, M M Murakami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1988
Pharmacokinetics and toxicity of high doses of antibody Fab fragments in ratsP R Pentel, D E Keyler, D G Gilbertson, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 5, 2013
Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacyD E Keyler, I Gawarammana, J M Gutiérrez, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 13, 2006
Differential effects of passive immunization with nicotine-specific antibodies on the acute and chronic distribution of nicotine to brain in ratsP R Pentel, M B Dufek, S A Roiko, et al.
International Journal of Immunopharmacology|January 1, 1991
Drug-specific F(ab')2 fragment reduces desipramine cardiotoxicity in ratsG J Brunn, D E Keyler, C A Ross, et al.
Bioconjugate Chemistry|September 1, 1994
Glutaramyl-beta-alanyl spacer group for haptenic coupling to proteins. Preparation of immunogens for antibody production against polychlorinated biphenylsD J Goon, H T Nagasawa, D E Keyler, et al.
International Immunopharmacology|July 29, 2008
Enhanced immunogenicity of a bivalent nicotine vaccineD E Keyler, S A Roiko, C A Earley, et al.
Annals of Emergency Medicine|September 1, 1995
Reduction of desipramine cardiotoxicity and prolongation of survival in rats with the use of polyclonal drug-specific antibody Fab fragmentsP R Pentel, W Scarlett, C A Ross, et al.
Pageof 5